How to Evaluate Cannabis Stocks in Changing Regulations

The cannabis industry offers some of the most asymmetric risk-reward opportunities in public markets today, but evaluating these stocks requires a completely different framework than traditional equity analysis. What works for tech stocks or consumer goods companies will lead you to catastrophic losses in cannabis. The regulatory moat around this sector isn’t about competitive advantage—it’s […]